A detailed history of D. E. Shaw & Co., Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 258,399 shares of JAZZ stock, worth $30.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
258,399
Holding current value
$30.8 Million
% of portfolio
0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $254,240 - $294,183
2,528 Added 0.99%
258,399 $28.8 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $5.02 Million - $5.74 Million
48,270 Added 23.25%
255,871 $27.3 Million
Q1 2024

May 15, 2024

SELL
$115.19 - $132.77 $5.32 Million - $6.13 Million
-46,194 Reduced 18.2%
207,601 $25 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $2.91 Million - $3.46 Million
25,462 Added 11.15%
253,795 $31.2 Million
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $5.05 Million - $6.01 Million
-41,387 Reduced 15.34%
228,333 $29.6 Million
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $16.2 Million - $19.4 Million
132,137 Added 96.04%
269,720 $33.4 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $5.66 Million - $6.78 Million
42,247 Added 44.31%
137,583 $20.1 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $12.4 Million - $15.2 Million
95,336 New
95,336 $15.2 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $49,626 - $60,307
414 Added 7.32%
6,068 $773,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $1.59 Million - $2.29 Million
-12,374 Reduced 68.64%
5,654 $736,000
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $213,706 - $248,684
1,334 Added 7.99%
18,028 $3.2 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $587,092 - $678,211
3,909 Added 30.57%
16,694 $2.74 Million
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $290,144 - $340,333
-2,062 Reduced 13.89%
12,785 $2.11 Million
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $4.11 Million - $5.61 Million
-38,929 Reduced 72.39%
14,847 $2.12 Million
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $2.02 Million - $2.57 Million
-21,061 Reduced 28.14%
53,776 $5.93 Million
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $22.4 Million - $39 Million
-255,266 Reduced 77.33%
74,837 $7.46 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $12.9 Million - $16.9 Million
109,891 Added 49.9%
330,103 $49.3 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $25.3 Million - $28.9 Million
201,832 Added 1098.11%
220,212 $28.2 Million
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $9.22 Million - $10.6 Million
-73,446 Reduced 79.98%
18,380 $2.62 Million
Q1 2019

May 15, 2019

SELL
$121.81 - $142.95 $8.51 Million - $9.99 Million
-69,889 Reduced 43.22%
91,826 $13.1 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $7.32 Million - $10.5 Million
63,100 Added 63.99%
161,715 $20 Million
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $10.8 Million - $12.1 Million
67,127 Added 213.18%
98,615 $16.6 Million
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $10.6 Million - $13.3 Million
-72,726 Reduced 69.79%
31,488 $5.43 Million
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $9.67 Million - $11.2 Million
-71,302 Reduced 40.62%
104,214 $15.7 Million
Q4 2017

Feb 14, 2018

BUY
$131.06 - $150.39 $17.9 Million - $20.5 Million
136,557 Added 350.51%
175,516 $23.6 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $5.56 Million - $6.06 Million
38,959
38,959 $5.7 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.47B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.